CAS: 108-13-4; Malonamide

相似化合物

107-91-5 120675-53-8 64017-81-8

上下游产品

CAS号109-77-3 丙二腈 | CAS号107-91-5 氰乙酰胺 | CAS号105-53-3 丙二酸二乙酯 | CAS号504-64-3 二氧化三碳 | CAS号7597-56-0 氨基甲酰乙酸乙酯 | CAS号6279-86-3 甲烷三羧酸三乙酯 | CAS号7664-41-7 氨 | CAS号19411-83-7 2-benzylidenepr... | CAS号41867-20-3 ethyl 3-amin°Cr... | CAS号10550-79-5 1,1,3,3-Propane... | CAS号35441-11-3 2,6-二羟基烟酰胺 | CAS号90-96-0 4,4'-二甲氧基二苯甲酮 | CAS号100-09-4 对甲氧基苯甲酸 | CAS号462-60-2 海因酸 | CAS号19411-83-7 2-benzylidenepr... | CAS号1903-90-8 6-Hydroxy-2-(me...

专利信息

专利号:US-5219988-A
优先权日:1989-02-22
标 题 :Gem-diamino derivatives and their use in the synthesis of retro-inverso peptides
发明人：GAZERRO LAURA; PINORI MASSIMO; VERDINI ANTONIO S
权利人:ENIRICERCHE SPA; SCLAVO SPA
摘要:This invention relates to new gem-diamino derivatives of general formula (I) ##STR1## where R is the side chain of an amino acid, of which any functional groups are suitably protected, and n X is an acyl group chosen from the group consisting of 2-nitrobenzoyl, 4-chloro-butyryl, acetoacetyl, 4-bromo-butyryl, (2-nitrophenoxy)-acetyl and 2-methyl-2-(2'-nitro-phenoxy)propionyl, of use in introducing gem-diamino residues into retro-inverso peptides. The invention further relates to a method for the synthesis of retro-inverso peptides in which the gem-diamino residue or residues are introduced using the new compound (I).

专利号:US-4866175-A
优先权日:1966-11-08
标 题 :Novel process for the synthesis of quinoxaline and benzimidazole-N-oxides
发明人：ISSIDORIDES COSTAS H; HADDADIN MAKHLUF J
权利人:RESEARCH CORP
摘要:The synthesis of quinoxaline and benzimidazole-N-oxides and of ester amd amide derivatives of 3-hydroxy-2-quinoxalinecarboxylic acid by a movel process consisting of the reaction between a benzofuroxan and an activated methylene-containing compound under basic conditions.

专利号:US-7723539-B2
优先权日:2004-06-16
标题:Catalysts based on metal complexes for the synthesis of optically active chrysanthemic acid
发明人：CARLONI SILVIA; BORZATTA VALERIO; MORONI LENI; TANZI GIADA; SARTORI GIOVANNI; MAGGI RAIMONDO
权利人:ENDURA SPA
摘要:Catalysts are described based on metal complexes derived from optically active s compounds, chosen from the classes consisting of bisoxazolines and salicylaldimines supported on an organic or inorganic matrix and employed in particular for the synthesis of optically active chrysanthemic acid.

专利号:US-8709129-B2
优先权日:2009-07-21
标题 :Compounds useful as ligands of actinides, their synthesis and their uses
发明人：MARIE CÉCILE; MIGUIRDITCHIAN MANUEL; BISSON JULIA; GUILLANEUX DENIS; DUBREUIL DIDIER
权利人:MARIE CÉCILE; MIGUIRDITCHIAN MANUEL; BISSON JULIA; GUILLANEUX DENIS; DUBREUIL DIDIER; COMMISSARIAT ENERGIE ATOMIQUE
摘要:The invention relates to novel compounds which are useful as ligands of actinides, to the synthesis of these compounds and to their uses. n These compounds fit the general formula (I) hereafter: n nwherein R 1 and R 2 , either identical or different, represent H, a linear or branched, saturated or unsaturated C 1 -C 12 hydrocarbon group, a phenyl, benzyl, diphenyl or tolyl group; R 3 represents H, a linear or branched, saturated or unsaturated C 1 -C 12 hydrocarbon group, a phenyl, tolyl or linear or branched C 1 -C 12 alkoxy group; while R 4 represents H, a linear or branched, saturated or unsaturated C 1 -C 12 hydrocarbon group, a phenyl or tolyl group.n n Field of applications: the processing of used nuclear fuels via a hydrometallurgical route.

专利号:US-6881847-B2
优先权日:2001-02-01
标题:Process for the synthesis and recovery of nitramines
发明人：HIGHSMITH THOMAS K; HANKS JAMI M; VELARDE STEPHEN P; BOTTARO JEFFREY
权利人:ALLIANT TECHSYSTEMS INC
摘要:A method is provided for the synthesis of nitramines and the recovery of the nitramines from a clathrate.

专利号:US-7038037-B2
优先权日:2002-06-20
标题 :Method for sequential support-bound synthesis of conjugated oligomeric compounds
发明人：MAIER MARTIN A; GUZAEV ANDREI P; MANOHARAN MUTHIAH
权利人:ISIS PHARMACEUTICALS INC
摘要:A sequential support-bound synthesis method is disclosed for preparing a conjugated oligomeric compound, preferably a PNA-peptide conjugate or an oligonucleotide-peptide conjugate, using a bridging molecule having at least two N-protecting amino groups. A conjugated oligomeric compound for therapeutic or prophylactic delivery is also disclosed.